Concepedia

Publication | Open Access

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

DOIFull Paper Access

1.1K

Citations

26

References

2015

Year

Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach, Hareth Nahi, Peter Gimsing, Markus Hansson, Monique C. Minnema, Ulrik Lassen, Jakub Krejcik, Antonio Palumbo,
New England Journal of Medicine

Abstract

Daratumumab monotherapy had a favorable safety profile and encouraging efficacy in patients with heavily pretreated and refractory myeloma. (Funded by Janssen Research and Development and Genmab; ClinicalTrials.gov number, NCT00574288.).

References

YearCitations

Page 1